The influence of cytomegalovirus infections on patient and renal graft outcome: A 3-year, multicenter, observational study (post-ECTAZ study)

Transplantation Proceedings

Volumn 43, Issue 7, 2011, Pages 2630-2635

  Abou Ayache, R ^a   Bchler, M ^a   Le Pogamp, P ^a   Westeel, P F ^a   Le Meur, Y ^a   Etienne, I ^a   Hurault De Ligny, B ^a   Toupance, O ^a   Caillard, S ^a   Sinnasse Raymond, G ^a   Touchard, G ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DACLIZUMAB; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ARTICLE; CADAVER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052779957     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.050     Document Type: Article

References (33)

1. R. Abou-Ayache, M. Bchler, and P. Lepogamp CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A Nephrol Dialys Transplant 23 2008 2024
2. B. Naumnik, J. Malyszko, and L. Chyczewski Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients Transplant Proc 39 2007 2748
3. A. Bordils, J.S. Plumed, and D. Ramos Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients Transplant Proc 37 2005 3756
4. D.C. Brennan, and M.A. Schnitzler Long-term results of rabbit antithymocyte globulin and basiliximab induction N Engl J Med 359 2008 1736
5. A. Al Najjar, I. Etienne, and P. Le Pogamp Long-term results of monoclonal anti-IL2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation Transplant Proc 38 2006 2298
6. M. Taherimahmoudi, H. Ahmadi, and N. Baradaran Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors Transplant Proc 41 2009 2841
7. D. Lowance, H.-H. Neumayer, and C.M. Legendre Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation N Engl J Med 340 1999 1462
8. C. Paya, A. Humar, and E. Dominguez Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 4 2004 611
9. M. Pescovitz Benefits of cytomegalovirus prophylaxis in solid organ transplantation Transplantation 82 2006 S4
10. L. Parreira, M. Bruges, and A. Gaspar Prevention of cytomegalovirus disease in renal transplantation: single-center experience Transplant Proc 41 2009 877
11. F. Leroy, A. Sechet, and R. Abou Ayache Cytomegalovirus prophylaxis with intravenous polyvalent Immunoglobulin in high-risk renal transplant recipients Transplant Proc 38 2006 2324
12. C. Pouteil-Noble, R. Ecochard, and G. Landrivon Cytomegalovirus infection, an etiological factor for acute rejection? A prospective study in 242 transplant patients Transplantation 55 1993 851
13. O. Toupance, M.C. Bouedjoro-Camus, and J. Carquin Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analysis Transplant Int 13 2000 413
14. S. Sagedal, K.P. Nordal, and A. Hartmann The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients Am J Transplant 2 2002 850
15. M. Giral, J.M. Nguyen, and P. Daguin Mycophenolate mofetil does not modify the incidence of cytomegalovirus disease after kidney transplantation but prevents CMV-induced chronic graft dysfonction J Am Soc Nephrol 12 2001 1758
16. A. Humar, K.J. Gillingham, and W.D. Payne Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients Transplantation 68 1999 1879
17. S. Sagedal, A. Hartmann, and K.P. Nordal Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival Kidney Int 66 2004 329
18. G. Opelz, B. Dohler, and A. Ruhenstroth Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2004 928
19. A.P. Limaye, R. Bakthavatsalam, and H.W. Kim Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis Transplantation 81 2006 1645
20. J.S. Chen, L.S. Li, and D.R. Cheng Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia Transplant Proc 41 2009 1639
21. C. Söderberg-Naucler Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259 2006 219
22. R. Manez, M.C. Breinig, and P. Linden Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease J Infect Dis 176 1997 1462
23. J. Hjelmesaeth, F. Mller, and A. Hartmann Is there a link between cytomegalovirus infection and new-onset posttransplantation diabete mellitus? Potential mechanisms of virus induced β-cell damage Nephrol Dial Transplant 20 2005 2311
24. M. Ardalan, and M.M. Shoja Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient Transplant Proc 41 2009 2915
25. R.S. Kalil, S.L. Hudson, and R.S. Gaston Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus? Am J Transplant 3 2003 79
26. E. Gómez, A. Laurés, and J.M. Baltar Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation Transplantation Proc 37 2005 3760
27. A. Humar, K.J. Gillingham, and W.D. Payne Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease Transplantation 70 2000 310
28. M.E. Falagas, D.R. Snydman, and J. Griffith Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients Boston Center for Liver Transplantation CMVIG Study Group Clin Infect Dis 23 1996 468
29. M.J. George, D.R. Snydman, and B.G. Werner The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients Boston Center for Liver Transplantation CMVIG-Study Group Am J Med 103 1997 106
30. D.C. Brennan Cytomegalovirus in renal transplantation J Am Soc Nephrol 12 2001 848
31. J. Cinati Jr, J.-U. Vogel, and R. Kotchetkov Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression FEMS Microbiol Rev 28 2004 59
32. B. Bruno, R. Sorasio, and P. Barozzi Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation Eur J Haematol 76 2006 342
33. R.R. Razonable, K.W. Burak, and H. Van Cruijsen The pathogenesis of hepatitis C virus is influenced by cytomegalovirus Clin Infect Dis 35 2002 974